selexipag
Showing 1 - 13 of 13
Sarcoidosis-associated Pulmonary Hypertension Trial in Worldwide (Selexipag, Placebo)
Active, not recruiting
- Sarcoidosis-associated Pulmonary Hypertension
- Selexipag
- Placebo
-
Indianapolis, Indiana
- +38 more
Jan 31, 2023
Pulmonary Arterial Hypertension Trial (Selexipag, Riociguat, CardioMEMS pulmonary artery pressure monitor)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Selexipag
- +3 more
- (no location specified)
Apr 11, 2023
Pulmonary Hypertension, Schistosomiasis Trial in São Paulo (Selexipag)
Unknown status
- Pulmonary Hypertension
- Schistosomiasis
- Selexipag
-
São Paulo, SP, BrazilUniversidade de São Paulo
Oct 8, 2020
Pulmonary Arterial Hypertension Trial in Worldwide (Selexipag, Placebo)
Completed
- Pulmonary Arterial Hypertension
- Selexipag
- Placebo
-
Torrance, California
- +38 more
Feb 4, 2021
Pulmonary Arterial Hypertension Trial in Worldwide (Macitentan, Tadalafil, Selexipag)
Healthy Subjects Trial in Merksem (Selexipag, Clopidogrel)
Completed
- Healthy Subjects
- Selexipag
- Clopidogrel
-
Merksem, BelgiumClinical Pharmacology Unit (CPU)
May 31, 2018
Pulmonary Arterial Hypertension Trial in United States (Selexipag)
Completed
- Pulmonary Arterial Hypertension
- Selexipag
-
La Jolla, California
- +14 more
Dec 28, 2017
Pulmonary Arterial Hypertension Trial in Worldwide (Selexipag, Placebo)
Completed
- Pulmonary Arterial Hypertension
- Selexipag
- Placebo
-
Mobile, Alabama
- +181 more
Dec 13, 2017
Healthy Subjects Trial in Kiel (Selexipag, Gemfibrozil, Rifampicin)
Completed
- Healthy Subjects
- Selexipag
- +2 more
-
Kiel, GermanyInvestigator Site
Jul 20, 2016
Raynaud's Phenomenon Secondary to Systemic Sclerosis Trial in France, Germany, United Kingdom (Selexipag, Placebo)
Completed
- Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Selexipag
- Placebo
-
Grenoble cedex, France
- +15 more
May 9, 2016
Cardiodynamics, Safety, Tolerability Trial in Evansville (selexipag, for selexipag, moxifloxacin)
Completed
- Cardiodynamics
- +3 more
- selexipag
- +3 more
-
Evansville, IndianaCovance Clinical Research Unit
Jul 30, 2014
Bioequivalence Trial in Groningen (selexipag)
Completed
- Bioequivalence
- selexipag
-
Groningen, NetherlandsQPS
Jul 30, 2014